203 related articles for article (PubMed ID: 22160274)
21. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
[TBL] [Abstract][Full Text] [Related]
22. Predictors of Higher Frequency of Atrial Fibrillation in Patients with Cardiac Resynchronization Therapy.
Grbović A; Pavlović S; Žugić V
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138281
[No Abstract] [Full Text] [Related]
23. How to Improve Cardiac Resynchronization Therapy Benefit in Atrial Fibrillation Patients: Pulmonary Vein Isolation (and Beyond).
Gianni C; Di Biase L; Mohanty S; Gökoğlan Y; Güneş MF; Al-Ahmad A; Burkhardt JD; Natale A
Card Electrophysiol Clin; 2015 Dec; 7(4):755-64. PubMed ID: 26596817
[TBL] [Abstract][Full Text] [Related]
24. Cardiac resynchronization therapy defibrillators in patients with permanent atrial fibrillation.
Rapacciuolo A; Iacopino S; D'Onofrio A; Curnis A; Pisanò EC; Biffi M; Della Bella P; Dello Russo A; Caravati F; Zanotto G; Calvi V; Rovaris G; Senatore G; Nicolis D; Santamaria M; Giammaria M; Maglia G; Duca A; Ammirati G; Romano SA; Piacenti M; Celentano E; Bisignani G; Vaccaro P; Miracapillo G; Bertini M; Nigro G; Giacopelli D; Gargaro A; Bisceglia C
ESC Heart Fail; 2021 Dec; 8(6):5204-5212. PubMed ID: 34514741
[TBL] [Abstract][Full Text] [Related]
25. Determinants of New-Onset Atrial Fibrillation in Patients Receiving CRT: Mechanistic Insights From Speckle Tracking Imaging.
Sade LE; Atar I; Özin B; Yüce D; Müderrisoğlu H
JACC Cardiovasc Imaging; 2016 Feb; 9(2):99-111. PubMed ID: 26684972
[TBL] [Abstract][Full Text] [Related]
26. Impact of atrioventricular junction ablation and CRT-D on long-term mortality in patients with left ventricular dysfunction, permanent, refractory atrial fibrillation, and narrow QRS: Results of a propensity-matched analysis.
Palmisano P; Ziacchi M; Ammendola E; Dell'Era G; Guerra F; Donateo P; Del Giorno G; Laffi M; Coluccia G; Bartoli L; Gaggioli G; Carbone A; Senes J; Dello Russo A; Patti G; Nigro G; Biffi M; Accogli M
J Cardiovasc Electrophysiol; 2022 Nov; 33(11):2288-2296. PubMed ID: 35930617
[TBL] [Abstract][Full Text] [Related]
27. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
[TBL] [Abstract][Full Text] [Related]
28. Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks.
van Boven N; Theuns D; Bogaard K; Ruiter J; Kimman G; Berman L; VAN DER Ploeg T; Kardys I; Umans V
J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1116-22. PubMed ID: 23889733
[TBL] [Abstract][Full Text] [Related]
29. Cardiac resynchronization therapy in patients with heart failure and atrial fibrillation: importance of new-onset atrial fibrillation and total atrial conduction time.
Buck S; Rienstra M; Maass AH; Nieuwland W; Van Veldhuisen DJ; Van Gelder IC
Europace; 2008 May; 10(5):558-65. PubMed ID: 18356205
[TBL] [Abstract][Full Text] [Related]
30. Incidence of paroxysmal atrial tachycardias in patients treated with cardiac resynchronization therapy and continuously monitored by device diagnostics.
Leclercq C; Padeletti L; Cihák R; Ritter P; Milasinovic G; Gras D; Paul V; Van Gelder IC; Stellbrink C; Rieger G; Corbucci G; Albers B; Daubert JC;
Europace; 2010 Jan; 12(1):71-7. PubMed ID: 19864311
[TBL] [Abstract][Full Text] [Related]
31. Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy.
Boriani G; Gasparini M; Landolina M; Lunati M; Proclemer A; Lonardi G; Iacopino S; Rahue W; Biffi M; DiStefano P; Grammatico A; Santini M;
Eur J Heart Fail; 2011 Aug; 13(8):868-76. PubMed ID: 21558331
[TBL] [Abstract][Full Text] [Related]
32. Long-term effects of cardiac resynchronisation therapy in patients with atrial fibrillation.
Khadjooi K; Foley PW; Chalil S; Anthony J; Smith RE; Frenneaux MP; Leyva F
Heart; 2008 Jul; 94(7):879-83. PubMed ID: 18208826
[TBL] [Abstract][Full Text] [Related]
33. Effects of atrioventricular nodal ablation on permanent atrial fibrillation patients with cardiac resynchronization therapy: a systematic review and meta-analysis.
Yin J; Hu H; Wang Y; Xue M; Li X; Cheng W; Li X; Yan S
Clin Cardiol; 2014 Nov; 37(11):707-15. PubMed ID: 25156448
[TBL] [Abstract][Full Text] [Related]
34. Association of heart rate with mortality in sinus rhythm and atrial fibrillation in heart failure with preserved ejection fraction.
Sartipy U; Savarese G; Dahlström U; Fu M; Lund LH
Eur J Heart Fail; 2019 Apr; 21(4):471-479. PubMed ID: 30698317
[TBL] [Abstract][Full Text] [Related]
35. Impact of atrial fibrillation on 1-year outcome in patients with implantable cardioverter defibrillator or cardiac resynchronization therapy with defibrillator: results from the German DEVICE Registry.
Feickert S; Ewertsen NC; Köbe J; Kleemann T; Jehle J; Senges J; Hochadel M; Andresen D; Stellbrink C; Eckardt L; Spitzer S; Brachmann J; Ince H; D'Ancona G
J Thorac Dis; 2024 Mar; 16(3):1825-1835. PubMed ID: 38617758
[TBL] [Abstract][Full Text] [Related]
36. Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review.
Ganesan AN; Brooks AG; Roberts-Thomson KC; Lau DH; Kalman JM; Sanders P
J Am Coll Cardiol; 2012 Feb; 59(8):719-26. PubMed ID: 22340263
[TBL] [Abstract][Full Text] [Related]
37. A Post hoc analysis on rhythm and high intensity interval training in cardiac resynchronization therapy.
Melo X; Abreu A; Santos V; Cunha P; Oliveira M; Pinto R; Carmo M; Fernhall B; Santa-Clara H
Scand Cardiovasc J; 2019 Aug; 53(4):197-205. PubMed ID: 31221002
[No Abstract] [Full Text] [Related]
38. Long-term survival in patients treated with cardiac resynchronization therapy: a 3-year follow-up study from the InSync/InSync ICD Italian Registry.
Gasparini M; Lunati M; Santini M; Tritto M; Curnis A; Bocchiardo M; Vincenti A; Pistis G; Valsecchi S; Denaro A;
Pacing Clin Electrophysiol; 2006 Dec; 29 Suppl 2():S2-10. PubMed ID: 17169128
[TBL] [Abstract][Full Text] [Related]
39. Gender-related safety and efficacy of cardiac resynchronization therapy.
Schuchert A; Muto C; Maounis T; Frank R; Ella RO; Polauck A; Padeletti L;
Clin Cardiol; 2013 Nov; 36(11):683-90. PubMed ID: 24105909
[TBL] [Abstract][Full Text] [Related]
40. Long-term symptom improvement and patient satisfaction after AV-node ablation vs. pulmonary vein isolation for symptomatic atrial fibrillation: results from the German Ablation Registry.
Wasmer K; Hochadel M; Wieneke H; Spitzer SG; Brachmann J; Straube F; Tebbenjohanns J; Groschup G; Heisel A; Lewalter T; Senges J; Eckardt L
Clin Res Cardiol; 2019 Apr; 108(4):395-401. PubMed ID: 30194475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
